Supply Chain

The agency is recommending that hospitals, health systems and clinics use the FDA-approved drug when available.

Tariffs and drug pricing reforms are a top priority, overtaking traditional concerns such as workforce challenges and cybersecurity.

Dr. Sophia Toya prescribed thousands of orthotic braces that were not medically necessary, DOJ says.

Almost three-quarters of respondents say they're concerned specifically about revenue growth and operating profitability.

Tax policy has shifted drug manufacturing to Switzerland, Ireland and Germany, says Johns Hopkins expert.

The order was released as Trump says he will soon announce plans to impose pharmaceutical tariffs.

Volatility of Trump's tariff policies is causing executives to take a wait and see approach, says advisor.

Hospitals and drugmakers are urging the president to exempt pharmaceuticals and medical goods from his new tariffs on Chinese imports.

Health systems need to know the ROI before they purchase technology, as CIOs and CFOs are looking at costs at a new level, says David Kirshner, managing partner at LogicSource and former CFO of Boston Children’s Hospital.  

Hospitals had 50% more product available to them this past week as compared to the week prior, HHS says.